LDLR and fatty liver disease: Moreover, in an atherogenesis-favoring background (i.e., low-density lipoprotein receptor (LDLR) KO mice under high-fat diet (HFD)), GSK3α deficiency led to smaller atherosclerotic lesions, increased anti-inflammatory IL-10 levels in the plasma, and attenuated hepatic steatosis [41].